Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
暂无分享,去创建一个
O. Pankewycz | R. Kohli | M. Laftavi | S. Patel | M. Said | E. Weber-Shrikant | M. Alnimri | M. Said
暂无分享,去创建一个
O. Pankewycz | R. Kohli | M. Laftavi | S. Patel | M. Said | E. Weber-Shrikant | M. Alnimri | M. Said